M. Malinowska et al.
131.2, 129.5, 129.4, 128.5, 123.5, 53.0, 49.5, 48.1, 20.4,
18.3 ppm; MS (EI ?): m/z = 148 (MesNHCH?2 •), 313
(M?).
resulting red solid, the imidazolinium salt (2 equiv.) and
t-BuOK (2 equiv.) were placed in a flame dried Schlenk
tube and dry toluene was added. The mixture was stirred
for 30 min at 80 °C in a preheated oil bath. The progress of
the reaction was monitored by TLC (hexane-AcOEt, v/v
7:3). After complete consumption of substrate the reaction
mixture was cooled down to room temperature and the
solvent was evaporated. The crude product was purified by
a silica gel chromatography to afford the expected product.
1-Mesityl-3-(2-nitrobenzyl)imidazolinium chloride
(13a, C19H22ClN3O2)
To a suspension of 1.548 g 12a (4.95 mmol) in methanol,
1 cm3 of conc. HCl (9.89 mmol) was added. The solvent
was evaporated, and the dihydrochloride was treated with
7.5 cm3 of trimethyl orthoformate. The reaction mixture
was refluxed under Ar atmosphere for 2 h, and the solvent
was evaporated in vacuo. The residue was dissolved in a
small volume of methylene chloride, and the product was
precipitated with diethyl ether to yield 13a (1.373 g; 77 %)
as a white solid. M.p.: 195–199 °C; IR: v = 3372, 2918,
[[1-Mesityl-3-(2-nitrobenzyl)-2-imidazolidinylidene]-
dichloro-(3-phenyl-1H-inden-1-ylidene)(tricyclo-
hexylphosphine)]ruthenium(II)
(14a, C52H64Cl2N3O2PRu)
General procedure was followed using 26 mg
3
1635, 1518, 1341 cm-1 1H NMR (400 MHz, CDCl3):
;
(0.028 mmol), 20 mg salt 13a (0.056 mmol), and 6 mg
t-BuOK (0.056 mmol). FC (hexane-AcOEt, v/v 8:1) yielded
4 mg of a carmine solid (15 %). IR: v = 3726, 2924, 2850,
d = 9.46 (s, 1H, CH), 8.33 (d, 1H, J = 7.7 Hz, H-Ar), 8.10
(d, 1H, J = 8.2 Hz, H-Ar), 7.78 (t, 1H, J = 7.5 Hz, H-Ar),
7.62 (t, 1H, J = 7.3 Hz, H-Ar), 6.94 (s, 2H, H-Ar), 5.57 (s,
2H, CH2), 4.33-4.27 (m, 2H, CH2), 4.16-4.10 (m, 2H,
CH2), 2.32 (s, 6H, 2x o–CH3), 2.29 (s, 3H, p-CH3) ppm;
13C NMR (100 MHz, CDCl3): d = 159.7, 148.5, 140.0,
135.0, 134.6, 133.4, 130.3, 129.7, 127.8, 125.2, 51.0, 48.7,
48.6, 20.8, 17.7 ppm; MS (ES?): m/z = 324 ([M–Cl]?).
1
1525, 1488, 1444, 1344, 1269 cm-1; H NMR (400 MHz,
CDCl3): d = 8.60 (d, 1H, J = 6.9 Hz, H-Ar), 8.43 (d, 1H,
J = 7.2 Hz, H-Ar), 8.01 (dd, 1H, J = 8.7, 1.2 Hz, H-Ar),
7.77 (m, 1H, H-Ar), 7.72 (m, 2H, H-Ar), 7.53 (m, 3H, H-Ar),
7.42 (t, 3H, J = 7.6 Hz, H-Ar), 7.21 (s, 1H, H-Ar), 7.17-
7.24 (m, 1H, H-Ar), 7.05 (m, 1H, H-Ar), 6.43 (s, 1H, H-Ar),
6.04 (s, 2H, CH2), 3.74 (m, 4H, 2x CH2), 2.25-3.25 (m, 3H,
Cy), 2.18 (s, 3H, -CH3), 2.06 (s, 3H, -CH3), 1.90 (s, 3H,
-CH3), 1.21–1.40 (m, 13H, Cy), 1.12-1.01 (m, 7H, Cy),
0.87–0.97 (m, 10H, Cy) ppm; 13C NMR (100 MHz, CDCl3):
d = 291.8, 188.1, 149.8, 140.5, 137.3, 137.1, 136.8, 134.1,
133.7, 133.5, 132.1, 130.9, 129.6, 128.9, 128.6, 128.5,
128.1, 128.0, 127.7, 127.4, 127.3, 126.4, 124.2, 116.1, 52.1,
50.7, 48.8, 35.6, 35.0, 32.8, 32.7, 29.6, 29.4, 27.8, 27.7, 27.6,
27.5, 27.0, 26.9, 26.3, 26.1, 21.0, 18.5, 18.4 ppm; MS
1-Mesityl-3-(4-nitrobenzyl)imidazolinium chloride
(13b, C19H22ClN3O2)
Trimethyl orthoformate (9.5 cm3, 82 mmol) was added to
1.280 g 12b (4.08 mmol) and 765 mg ammonium chloride
(14.3 mmol). The reaction mixture was refluxed, and the
progress of reaction was monitored by TLC. After 2 h the
solvent was evaporated, and the crude product was
dissolved in a small volume of methylene chloride. The
product 13b (1.177 g; 80 %) was precipitated as a white
solid with diethyl ether. M.p.: 267 °C; IR: v = 3383, 3038,
(ESI?): m/z = 988 ([M ? Na]?), 930 ([M-Cl]?); HR-MS
35
64
(ESI?): m/z calcd for C52H ClN3O2P102Ru [M-Cl]?
1632, 1518, 1337 cm-1 1H NMR (400 MHz, CDCl3):
;
930.3509, found 930.3468 (4.4 ppm).
d = 10.37 (s, 1H, CH), 8.25 (d, 2H, J = 8.3 Hz, H-Ar),
7.80 (d, 2H, J = 8.4 Hz, H-Ar), 6.92 (s, 2H, H-Ar), 5.47 (s,
2H, CH2), 4.11 (s, 4H, CH2), 2.30 (s, 6H, 2x CH3), 2.28 (s,
3H, CH3) ppm; 13C NMR (100 MHz, CDCl3): d = 160.1,
148.1, 140.4, 140.3, 134.9, 130.4, 130.3, 129.9, 124.2,
51.0, 48.3, 20.9, 18.0 ppm; MS (ES ?): m/z = 324
([M–Cl]?).
[[1-Mesityl-3-(2-nitrobenzyl)-2-imidazolidinylidene]-
dichloro-(3-phenyl-1H-inden-1-ylidene)(tricyclohexylphos-
phine)]ruthenium(II)
(14b, C52H64Cl2N3O2PRu)
General procedure was followed using 26 mg
3
(0.028 mmol), 20 mg salt 13b (0.056 mmol), and 6 mg
t-BuOK (0.056 mmol). FC (hexane-AcOEt, v/v 8:1)
yielded 6 mg of a carmine solid (22 %). IR: v = 3734,
3625, 2920, 2850, 1526, 1488, 1445, 1269 cm-1; 1H NMR
(400 MHz, CDCl3): d = 8.60 (d, 1H, J = 7.4 Hz, H-Ar),
8.42 (d, 1H, J = 7.1 Hz, H-Ar), 8.01 (dd, 1H, J = 8.2,
1.1 Hz, H-Ar), 7.77 (m, 1H, H-Ar), 7.71 (m, 2H, H-Ar),
7.53 (m, 2H, H-Ar), 7.42 (m, 2H, H-Ar), 7.25-7.15 (m, 3H,
H-Ar), 7.20 (s, 1H, H-Ar), 7.05 (m, 1H, H-Ar), 6.43 (s, 1H,
H-Ar), 6.04 (s, 2H, CH2), 3.76-3.72 (m, 4H, 2x CH2), 2.37-
2.32 (m, 3H, Cy), 2.18 (s, 3H, -CH3), 2.06 (s, 3H, -CH3),
1.89 (s, 3H, -CH3), 1.82-0.86 (m, 30H, Cy) ppm; 13C NMR
General procedure for the preparation of catalysts
14a and 14b
The catalyst 3 (1 equiv.) was placed in a flame dried
Schlenk tube and dry hexane was added under Ar atmo-
sphere. To this suspension dry pyridine (10 equiv.) was
added. The mixture was stirred 1 h at room temperature
before adding dry hexane. The suspension was stored at
-20 °C overnight. The resulting precipitate was filtered and
washed with hexane and dried under vacuum. Next the
123